GLOVEMAKERS in Singapore and Malaysia, as well as personal protective equipment maker Medtecs International : 546 0%, have suffered hits in terms of profitability and market values amid the easing of the coronavirus pandemic. 

These counters booked record-high profit and revenue figures during the height of the pandemic. Their share prices rose as new virus variants were discovered and investors piled into the stocks.

But with the roll-out of vaccines and easing of restrictions on capacity limits and group sizes, the prospects for these companies are dimming.